Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 283-293

  Sellati, Timothy J ^a   Wilkinson, David A ^a   Sheffield, Jeanne S ^a   Koup, Richard A ^a   Radolf, Justin D ^a   Norgard, Michael V ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LIPOPEPTIDE; LIPOPROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; BACTERIAL VIRULENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TREPONEMA PALLIDUM; VIRUS TRANSMISSION;

ADULT; CHEMOKINES; HIV INFECTIONS; HIV-1; HUMANS; LIPOPROTEINS; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTES; PROTEIN BINDING; RECEPTORS, CCR5; RECEPTORS, CXCR4; SYPHILIS; TREPONEMA PALLIDUM;

EID: 0033983314     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315209     Document Type: Article

References (80)

1. 1. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
2. 2. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. Sex Transm Dis 1996;23:429-40.
3. 3. Ansell DA, Hu TC, Straus M, Cohen M, Sherer R. HIV and syphilis seroprevalence among clients with sexually transmitted diseases attending a walk-in clinic at Cook County Hospital. Sex Transm Dis 1994;21:93-6.
4. 4. Lukehart SA, Holmes KK. Syphilis. In: Isselbacher KJ, Braunwald E, Wilson J, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw Hill, 1994:726-37.
5. 5. Sell S, Gamboa D, Baker Zander SA, Lukehart SA, Miller JN. Host response to Treponema pallidum in intradermally-infected rabbits: evidence for persistence of infection at local and distant sites. J Invest Dermatol 1980;75: 470-5.
6. 6. Tosca A, Lehou J, Hatjivasiliou M, Varelzidis A, Stratigos JD. Infiltrate of syphilitic lesions before and after treatment. Genitourin Med 1988;64: 289-93.
7. 7. Engelkens HJH, ten Kate FJW, Judanarso J, et al. The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med 1993;69:102-7.
8. 8. Wu SC, Spouge JL, Conley SR, Tsai WP, Merges MJ, Nara PL. Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages. J Virol 1995;69:6054-62.
9. 9. Cheng-Mayer C, Liu R, Landau NR, Stamatatos L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J Virol 1997;71:1657-61.
10. 10. Chesebro B, Wehrly K, Nishio J, Perryman S. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol 1996;70: 9055-9.
11. 11. Hardy PH Jr. Levin J. Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc Soc Exp Biol Med 1983;174:47-52.
12. 12. Radolf JD, Norgard MV. Pathogen-specificity of integral membrane proteins of Treponema pallidum subsp. pallidum identified by phase partitioning with Triton X-114. Infect Immun 1988;56:1825-8.
13. 13. Chamberlain NR, Brandt ME, Erwin AL, Radolf JD, Norgard MV. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect Immun 1989;57:2872-7.
14. 14. Schouls LM, Mout R, Dekker J, Van Embden JDA. Characterization of lipid-modified immunogenic proteins of Treponema pallidum expressed in Escherichia coli. Microb Pathog 1989;7:175-88.
15. 15. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J Immunol 1991;147:1968-74.
16. 16. Riley BS, Oppenheimer-Marks N, Hansen EJ, Radolf JD. Norgard MV. Virulent Treponema pallidum activates human vascular endothelial cells. J Infect Dis 1992;165:484-93.
17. 17. Akins DR, Purcell BK, Mitra M, Norgard MV, Radolf JD. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pullidum determines macrophage activation as well as amphiphilicity. Infect Immun 1993;61:1202-10.
18. 18. DeOgny L, Pramanik BC, Arndt LL, et al. Solid-phase synthesis of biologically active lipopeplides as analogs for spirochetal lipoproteins. Peptide Res 1994;7:91-7.
19. 19. Radolf JR, Arndt LL, Akins DR, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/ macrophages. J Immunol 1995;154:2866-77.
20. 20. Norgard MV, Riley BS, Richardson JA, Radolf JD. Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. Infect Immun 1995;63:1507-15.
21. 21. Norgard MV, Arndt LL, Akins DR, Curetty LL, Harrich DA, Radolf JD. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeplides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB. Infect Immun 1996;64:3845-52.
22. 22. Tai KF, Ma Y, Weis JJ. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun 1994;62:520-8.
23. 23. Weis JJ, Ma Y, Erdile LF. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994;62:4632-6.
24. 24. Wooten RM, Modur VR, McIntyre TM, Weis JJ. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-κB and inflammatory activation in human endothelial cells. J Immunol 1996;157:4584-90.
25. 25. Theus SA, Harrich DA, Gaynor R, Radolf JD. Norgard MV. Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-κB activation. J Infect Dis 1998;177:941-50.
26. 26. Sellati TJ, Bouis DA, Kitchens RL, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that utilized by lipopolysaccharide. J Immunol 1998;160:5455-64.
27. 27. Sellati TJ, Abrescia LD, Radolf JD, Furie MB. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun 1996;64:3180-7.
28. 28. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.
29. 29. Zhu T, Wang N, Carr A, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-107.
30. 30. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
31. 31. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-7.
32. 32. Deng D, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
33. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
34. 34. Robertson SM, Kettman JR, Miller JN, Norgard MV. Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols). Infect Immun 1982;36:1076-85.
35. 35. Riley BS, Oppenheimer-Marks N, Radolf JD, Norgard MV. Virulent Treponema pallidum promotes adhesion of leukocytes to human vascular endothelial cells. Infect Immun 1994;62:4622-5.
36. 36. Weigel LM, Brandt ME, Norgard MV. Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum. Infect Immun 1992;60:1568-76.
37. 37. Smith DB, Johnson KS, Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988; 67:31-40.
38. 38. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals hearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
39. 39. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-502.
40. 40. Trkola A, Dragic T, Arthos J, et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996;384: 184-7.
41. 41. Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OMZ, Wang JM. Monocyte chemotacitc protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 1997;272:11682-5.
42. 42. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning -a laboratory manual. 2d ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
43. + T cells. Science 1995;270:1811-5.
44. 44. Thomas DD, Navab M, Haake DA, Fogelman AM, Miller JN, Lovett MA. Treponema pallidum invades intracellular junctions of endothelial cell monolayers. Proc Natl Acad Sci USA 1988;85:3608-12.
45. 45. Fitzgerald TJ, Miller JN, Sykes JA. Treponema pallidum (Nichols strain) in tissue cultures: cellular attachment, entry, and survival. Infect Immun 1975;11:1133-40.
46. 46. Quist EE, Repesh LA, Zeleznikar R, Fitzgerald TJ. Interaction of Treponetna pallidum with isolated rabbit capillary tissues. Br J Vener Dis 1983;59: 11-20.
47. 47. Wong GHW, Steiner B, Faine S, Graves S. Factors affecting the attachment of Treponema pallidum to mammalian cells in vitro. Br J Vener Dis 1983;59: 21-9.
48. 48. Fitzgerald TJ, Repesh A, Blanco DR, Miller JN. Attachment of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I and blockage of attachment by immune rabbit IgG. Br J Vener Dis 1984;60:357-63.
49. 49. Thomas DD, Baseman JB, Alderete JF. Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain. J Exp Med 1985;161:514-25.
50. 50. Sica A, Saccani A, Borsatti A, et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997;185:969-74.
51. 51. Verani A, Scarlatti G, Comar M, et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997;185:805-16.
52. 52. Dada AJ, Ajayi AO, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex Transm Dis 1998;25:237 42.
53. 53. Moriuchi M, Moriuchi H, Turner W, Fauci AS. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J Clin Invest 1998;102:1540-50.
54. 54. Taub DD, Conlon K, LLoyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4 and CD8 T cells in response to MIP-1α and MIP-1β. Science 1993;260:355-8.
55. 55. Tedla N, Wang HW, McNeil HP, et al. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1α and MIP-1β. J Immunol 1998; 161:5663-72.
56. 56. Verani A, Pesenti E, Polo S, et al. Cutting edge: CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Jmmunol 1998;161:2084-8.
57. 57. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282: 2085-8.
58. 58. Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998;395:284-8.
59. 59. Trees DL, Morse SA. Chancroid and Haemophilus ducreyi: an update. Clin Microhiol Rev 1995;8:357-75.
60. 60. Campagnari AA, Wild LM, Griffiths GE, Karalus RJ, Wirth MA, Spinola SM. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Infect Immun 1991;59:2601-8.
61. 61. Ortiz-Zepeda C, Hernandez-Perez E, Marroquin-Burgos R. Gross and microscopic features in chancroid: a study in 200 new culture-proven cases in San Salvador. Sex Transm Dis 1994;21:112-7.
62. 62. Hiltke TJ, Campagnari AA, Spinola SM. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi. Infect Immun 1996;64: 5047-52.
63. 63. Spinola SM, Hiltke TJ, Fortney K, Shanks KL. The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL. Infect Immun 1996;64:1950-5.
64. 64. Zhang H, Peterson JW, Niesel DW, Klimpel GR. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol 1997;159:4868-78.
65. 65. Bour S, Geleziunas R, Wainberg MA. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev 1995;59:63-93.
66. 66. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992;66:1354-60.
67. 67. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity developing during the asymptomatic stage before disease progression. J Virol 1994;68:4400-8.
68. 68. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-8.
69. 69. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type I. J Infect Dis 1991;163:233-9.
70. 70. Padian NS, Shiboski SC, Jewell NP. Female to male transmission of human immunodeficiency virus. JAMA 1991;266:1664-7.
71. 71. Patterson BK, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract. Am J Pathol 1998; 153: 481-90.
72. 72. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
73. 73. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
74. 74. Oravecz T, Pall M, Wang J, Roderiquez G, Ditto M, Norcross MA. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J Immunol 1997;159:4587-92.
75. 75. Ohshiro Y, Murakami T, Matsuda K, Nishioka K, Yoshida K, Yamamoto N. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol Immunol 1996;40:827-35.
76. 76. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, Norcross MA. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 1995;69:2233-9.
77. 77. Patel M, Yanagishita M, Roderiquez G, et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 1993;9:167-74.
78. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocytes/macrophages. Proc Natl Acad Sci USA 1996;93:15341-5.
79. 79. Lukehart SA. Macrophages and host resistance. In: Schell RF, Musher DM, eds. Pathogenesis and immunology of treponemal infection. New York: Marcel Dekker, 1983:349-64.
80. 80. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512.